CNS Pharmaceuticals Inc (CNSP) — Financial Flexibility Index
CNS Pharmaceuticals Inc (CNSP) has a Financial Flexibility Index of -0.74x as of December 2025. Free cash flow of $-3.03 Million (operating CF $-3.05 Million minus capex $18.18K) represents -1% of total liabilities ($4.10 Million). Also explore CNS Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CNS Pharmaceuticals Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for CNS Pharmaceuticals Inc across 9 annual periods. Check CNS Pharmaceuticals Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for CNS Pharmaceuticals Inc (2017–2025)
Year-by-year free cash flow to debt coverage for CNS Pharmaceuticals Inc. For the full company profile including market capitalisation, see market cap of CNS Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.36x | $-13.79 Million | $-13.81 Million | $4.10 Million | ▲ +50.4% |
| 2024 | -6.78x | $-17.11 Million | $-17.11 Million | $2.52 Million | ▼ -194.0% |
| 2023 | -2.30x | $-14.14 Million | $-14.14 Million | $6.13 Million | ▼ -7.5% |
| 2022 | -2.14x | $-10.55 Million | $-10.56 Million | $4.92 Million | ▲ +66.2% |
| 2021 | -6.34x | $-13.53 Million | $-13.54 Million | $2.14 Million | ▼ -65.4% |
| 2020 | -3.83x | $-7.30 Million | $-7.32 Million | $1.91 Million | ▲ +66.3% |
| 2019 | -11.36x | $-3.53 Million | $-3.55 Million | $311.00K | ▼ -1854.9% |
| 2018 | -0.58x | $-716.38K | $-716.38K | $1.23 Million | ▼ -14.3% |
| 2017 | -0.51x | $-112.19K | $-112.20K | $220.73K | — |